Stocks
Amgen Inc.AMGN
NASDAQHealthcareBiotechnology$366.21-0.43%
A major biotechnology drugmaker focused on developing and manufacturing biologic therapies for serious illnesses including cancer, cardiovascular disease, and autoimmune disorders. Its portfolio includes established blockbusters such as Enbrel, Prolia, and Otezla alongside a growing biosimilars busi...
Market Cap: $197.4B52W Range: $261.43 – $391.29
Congressional Interest in Amgen Inc. (AMGN)
16 members of Congress have disclosed 50 trades in Amgen Inc. (AMGN), a Healthcare company. The buy/sell breakdown shows 20 purchases versus 30 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
16
Buys
20
Sells
30
Who in Congress Is Trading AMGN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-04-18 | JANE HARMAN | sell | $1K – $15K |
| 2026-03-30 | Rohit Khanna | sell | $1K – $15K |